Polymethyl Methacrylate and (PEGT/PBT) Centralizer by the Uncemented BIHAPRO THP
Primary Purpose
Osteoarthritis
Status
Terminated
Phase
Phase 3
Locations
Netherlands
Study Type
Interventional
Intervention
PGET
PMMA
Sponsored by

About this trial
This is an interventional treatment trial for Osteoarthritis focused on measuring Hip prosthesis, Centralizer, Uncemented
Eligibility Criteria
Inclusion Criteria: Age between 18 and 75 years Diagnosis: Osteoarthritis Indicated for a primary hip prosthesis Exclusion Criteria: Previous hip surgery No informed consent Active infection in hip Immature skeleton Rheumatoid arthritis, M. Paget
Sites / Locations
- Atrium medical centre
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
PGET
PMMA
Arm Description
Outcomes
Primary Outcome Measures
Alignment
Complications
Secondary Outcome Measures
Pain
Function
Full Information
NCT ID
NCT00214760
First Posted
September 16, 2005
Last Updated
January 29, 2010
Sponsor
Biomet Nederland BV
Collaborators
Atrium Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT00214760
Brief Title
Polymethyl Methacrylate and (PEGT/PBT) Centralizer by the Uncemented BIHAPRO THP
Official Title
Phase 3 Randomised, Prospective Study Comparing the PMMA and the Resorbable PEGT/PBT Centralizer by the Uncemented BIHAPRO Total Hip Prosthesis
Study Type
Interventional
2. Study Status
Record Verification Date
November 2009
Overall Recruitment Status
Terminated
Why Stopped
On of the liners has been taken from the market
Study Start Date
May 2005 (undefined)
Primary Completion Date
August 2008 (Actual)
Study Completion Date
September 2011 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
Biomet Nederland BV
Collaborators
Atrium Medical Center
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to analyse if the alignment of the stem and the number of complications of the new resorbable PEGT/PBT centralizer are comparable to the standard PMMA centralizer during the placement of an uncemented Bihapro hip prosthesis.
Detailed Description
For a correct placement and early fixation of an uncemented hip prosthesis, a centralizer is used. Normally, the centralizer is made of PMMA, the same material as bone cement. When a revision is needed, PMMA is difficult to remove, which is one of the reason not to use a cemented hip prosthesis. With a PMMA centralizer, still PMMA will remain in the bone and needs to be removed in case of a revision. PEGT/PBT is a reabsorbable material, which gives stability during the first month after the placement of the hip prosthesis. However, PEGT/PBT is reabsorped afterwards and, therefore, will not interfere with a revision procedure.
The goal of this study is to analyse if the PEGT/PBT is as safe as PMMA in terms of alignment, direct postoperative complications and clinical results.
Therefore, 100 patients indicated for a cementless Bihapro hip prosthesis which have signed an informed consent are included and randomised over the used centralizers using a weighted randomisation method. All patients will be treated equally. The patients are examined preoperatively, 1 day, 6 weeks, 3, 6, 12, 24 en 48 months postoperatively using an X-ray, the Harris hip score and a patient questionnaire, the Womac and SF36.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis
Keywords
Hip prosthesis, Centralizer, Uncemented
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
70 (Actual)
8. Arms, Groups, and Interventions
Arm Title
PGET
Arm Type
Experimental
Arm Title
PMMA
Arm Type
Active Comparator
Intervention Type
Device
Intervention Name(s)
PGET
Other Intervention Name(s)
resolbable liner
Intervention Description
resolbable liner
Intervention Type
Device
Intervention Name(s)
PMMA
Other Intervention Name(s)
cement liner
Intervention Description
cement liner
Primary Outcome Measure Information:
Title
Alignment
Time Frame
0,3,6,12,24 months
Title
Complications
Time Frame
all time points
Secondary Outcome Measure Information:
Title
Pain
Time Frame
0,3,6,12,24 months
Title
Function
Time Frame
0,3,6,12,24 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age between 18 and 75 years
Diagnosis: Osteoarthritis
Indicated for a primary hip prosthesis
Exclusion Criteria:
Previous hip surgery
No informed consent
Active infection in hip
Immature skeleton
Rheumatoid arthritis, M. Paget
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Joanne Bloemsaat-Minekus, PhD
Organizational Affiliation
Biomet Nederland
Official's Role
Principal Investigator
Facility Information:
Facility Name
Atrium medical centre
City
Heerlen
ZIP/Postal Code
6401CX
Country
Netherlands
12. IPD Sharing Statement
Citations:
PubMed Identifier
10580823
Citation
Hernandez-Vaquero D, Murcia-Mazon A, Paz-Jimenez J, Alegre-Mateo R, Martinez-Garcia J, Pena-Vazquez J. Behavior of the femoral stem in the Bihapro hip prosthesis. Orthopedics. 1999 Nov;22(11):1049-53. doi: 10.3928/0147-7447-19991101-13.
Results Reference
result
Learn more about this trial
Polymethyl Methacrylate and (PEGT/PBT) Centralizer by the Uncemented BIHAPRO THP
We'll reach out to this number within 24 hrs